Bleselumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bleselumab, covering 2022-01-05 to 2022-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients [Phase 2]